Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 15:17:4293-4306.
doi: 10.2147/IJN.S377816. eCollection 2022.

Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature

Mingxin Cao #  1 , Enyu Shi #  1 , Hanping Wang  1 , Lujia Mao  1 , Qiqi Wu  1 , Xinming Li  2 , Yanjie Liang  1 , Xiaoying Yang  3 , Yinsong Wang  1   3 , Changyi Li  1
Affiliations
Review

Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature

Mingxin Cao et al. Int J Nanomedicine. .

Abstract

Oral squamous cell carcinoma (OSCC) is the most common type of malignant tumor in the head and neck, with a poor prognosis mainly due to recurrence and metastasis. Classical treatment modalities for OSCC like surgery and radiotherapy have difficulties in dealing with metastatic tumors, and together with chemotherapy, they have major problems related to non-specific cell death. Molecular targeted therapies offer solutions to these problems through not only potentially maximizing the anticancer efficacy but also minimizing the treatment-related toxicity. Among them, the receptor-mediated targeted delivery of anticancer therapeutics remains the most promising one. As OSCC exhibits a heterogeneous nature, selecting the appropriate receptors for targeting is the prerequisite. Hence, we reviewed the OSCC-associated receptors previously used in targeted therapy, focused on their biochemical characteristics and expression patterns, and discussed the application potential in personalized targeted therapy of OSCC. We hope that a better comprehension of this subject will help to provide the fundamental information for OSCC personalized therapeutic planning.

Keywords: active targeting; drug delivery; oral squamous cell carcinoma; receptors; targeted therapy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Schematic illustration of target receptors in OSCC and OSCC-associated regions for anticancer drugs delivery.
Figure 2
Figure 2
The expression pattern and targeting efficiency of uPAR in OSCC.
See this image and copyright information in PMC

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Chow LQM. Head and Neck Cancer. N Engl J Med. 2020;382(1):60–72. doi: 10.1056/NEJMra1715715 - DOI - PubMed
    1. Allen CT, Law JH, Dunn GP, Uppaluri R. Emerging insights into head and neck cancer metastasis. Head Neck. 2013;35(11):1669–1678. doi: 10.1002/hed.23202 - DOI - PubMed
    1. Colevas AD, Yom SS, Pfister DG, et al. NCCN Guidelines Insights: head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018;16(5):479–490. doi: 10.6004/jnccn.2018.0026 - DOI - PubMed
    1. Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Semin Cancer Biol. 2020;61:71–83. doi: 10.1016/j.semcancer.2019.09.011 - DOI - PubMed

MeSH terms